Brooks C C, Tolan D R
Biology Department, Boston University, Massachusetts 02215.
FASEB J. 1994 Jan;8(1):107-13. doi: 10.1096/fasebj.8.1.8299883.
Hereditary fructose intolerance (HFI) is a potentially fatal autosomal recessive disease of carbohydrate metabolism. HFI patients are deficient in aldolase B, the isozyme expressed in fructose-metabolizing tissues. The eight protein coding exons, including splicing signals, of the aldolase B gene from one American HFI patient were amplified by the polymerase chain reaction (PCR). Single-strand conformational polymorphism (SSCP) analysis and direct sequence determination were applied to the amplified fragments. The mutations in the patient's alleles were identified as a nonsense mutation (R59op) in exon 3 and a missense mutation (C134R) in exon 5. These mutations were confirmed by sequence determination of cloned PCR-amplified exons 3 and 5 from the patient. Allele specific oligonucleotide (ASO) hybridizations of amplified exons 3 and 5 showed the Mendelian inheritance of both mutations. Site-directed mutagenesis was used to generate an expression plasmid for the C134R mutation, and the mutant enzyme was expressed in bacteria. Assays of partially purified enzyme preparations showed that this missense mutation results in an apparently unstable enzyme that retains partial activity. This is the first evidence for a partially active aldolase B from an HFI individual with an identified mutation, and supports the hypothesis that adequate gluconeogenesis/glycolysis is maintained in HFI patients by the presence of partially active enzymes.
遗传性果糖不耐受症(HFI)是一种碳水化合物代谢方面具有潜在致命性的常染色体隐性疾病。HFI患者缺乏醛缩酶B,这是一种在果糖代谢组织中表达的同工酶。采用聚合酶链反应(PCR)扩增了一名美国HFI患者醛缩酶B基因的8个蛋白质编码外显子,包括剪接信号。对扩增片段进行了单链构象多态性(SSCP)分析和直接测序。该患者等位基因中的突变被鉴定为外显子3中的无义突变(R59op)和外显子5中的错义突变(C134R)。通过对患者克隆的PCR扩增外显子3和5进行测序,证实了这些突变。对扩增的外显子3和5进行等位基因特异性寡核苷酸(ASO)杂交,结果显示这两种突变均符合孟德尔遗传规律。利用定点诱变技术构建了C134R突变的表达质粒,并在细菌中表达了突变酶。对部分纯化的酶制剂进行检测表明,这种错义突变导致酶明显不稳定,但仍保留部分活性。这是首次有证据表明来自一名具有已鉴定突变的HFI个体的醛缩酶B具有部分活性,支持了以下假说:HFI患者中由于存在部分活性酶而维持了足够的糖异生/糖酵解。